InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
1
T+90 胜率
0%
T+90 平均收益
-84.7%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the detailed record of transactions filed by Loerop James, Vice-Président Exécutif du Développement Commercial. Insider active across 3 companies, notably Anika Therapeutics, Inc.. Cumulatively, 15 filings have been recorded. Breakdown: 1 buy · 1 sell. Total volume traded: €148k. History available since 8 July 2021. The latest transaction was disclosed on 1 February 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Loerop James
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
20,875 股Common StockSEC:0001781549-26-000011:0
11,250 股Common StockSEC:0001781549-26-000009:0
15,980 股@ US$2.4817.1% 占其流量Common StockSEC:0001781549-26-000007:0
15,980 股@ US$2.4814.6% 占其流量Common StockSEC:0001781549-26-000005:0
73,750 股Common StockSEC:0001781549-26-000003:0
15,447 股@ US$2.4816.6% 占其流量Common StockSEC:0001415889-25-002938:3
7,500 股Common StockSEC:0001415889-25-002938:1
11,250 股Common StockSEC:0001415889-25-002938:0
14,750 股Common StockSEC:0001415889-25-002938:2
73,750 股Common StockSEC:0001415889-25-000622:0
11,250 股Common StockSEC:0001209191-24-002838:0
14,705 股@ US$6.797641.5% 占其流量Common StockSEC:0001209191-23-047522:0
标准退出：2023年11月26日 (T+90)
4,267 股@ US$13.890924.8% 占其流量Common StockSEC:0001209191-23-008451:0
11,250 股Common StockSEC:0001209191-23-006999:0
3,000 股0Common StockSEC:0001171843-21-004833:0
15 条申报中的 15 条
About Loerop James
Loerop James is Executive Vice President of Business Development. He has 15 filings in total, and across the 15 sampled filings the recorded volumes relate to Aclaris Therapeutics, Inc., with EUR 92336 of buys and EUR 55241 of sells, over the period from 2021-07-12 to 2026-02-05. The most common transaction nature is option exercise.
